Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 29

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Microneedle array patches for sustained delivery of fluphenazine: A micron scale approach for the management of schizophrenia

Abu Ershaid, Juhaina M., Vora, Lalitkumar K., Volpe-Zanutto, Fabiana, Sabri, Akmal H., Peng, Ke, Anjani, Qonita K., McKenna, Peter E., Ripolin, Anastasia, Larrañeta, Eneko, McCarthy, Helen O., Donnelly, Ryan F.·2023·Biomaterials Advances

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bioadv.2023.213526

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 81

  1. Rubinov, 2013, Schizophrenia and abnormal brain network hubs, Dialogues Clin. Neurosci., 15, 339, 10.31887/DCNS.2013.15.3/mrubinov · DOI · Paper page
  2. Jablensky, 2010, The diagnostic concept of schizophrenia: its history, evolution, and future prospects, Dialogues Clin. Neurosci., 12, 271, 10.31887/DCNS.2010.12.3/ajablensky · DOI · Paper page
  3. Chong, 2016, Global economic burden of schizophrenia: a systematic review, Neuropsychiatr. Dis. Treat., 12, 357
  4. Lehman, 2004, Practice guideline for the treatment of patients with schizophrenia, second edition, Am. J. Psychiatry, 161, 1
  5. Picco, 2022, 3d-printed implantable devices with biodegradable rate-controlling membrane for sustained delivery of hydrophobic drugs, Drug Deliv., 29, 1038, 10.1080/10717544.2022.2057620 · DOI
  6. Higashi, 2013, Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review, Ther. Adv. Psychopharmacol., 3, 200, 10.1177/2045125312474019 · DOI · Paper page
  7. Almond, 2004, Relapse in schizophrenia: costs, clinical outcomes and quality of life, Br. J. Psychiatry, 184, 346, 10.1192/bjp.184.4.346 · DOI · Paper page
  8. Pennington, 2017, The cost of relapse in schizophrenia, PharmacoEconomics, 35, 921, 10.1007/s40273-017-0515-3 · DOI
  9. Abruzzo, 2019, Transdermal delivery of antipsychotics: rationale and current status, CNS Drugs, 33, 849, 10.1007/s40263-019-00659-7 · DOI
  10. Jindal, 2023, Long-acting parenteral drug delivery systems for the treatment of chronic diseases, Adv. Drug Deliv. Rev., 198, 10.1016/j.addr.2023.114862 · DOI
  11. Vora, 2017, Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: in-vitro characterization and in-vivo pharmacokinetic studies, Eur. J. Pharm. Sci., 107, 78, 10.1016/j.ejps.2017.06.027 · DOI
  12. Pawar, 2022, Long-acting microspheres of human chorionic gonadotropin hormone: in-vitro and in-vivo evaluation, Int. J. Pharm., 611, 10.1016/j.ijpharm.2021.121312 · DOI
  13. Moffatt, 2022, Development and evaluation of dissolving microarray patches for co-administered and repeated intradermal delivery of long-acting rilpivirine and cabotegravir nanosuspensions for paediatric HIV antiretroviral therapy, Pharm. Res.
  14. Tekko, 2021, Novel bilayer microarray patch-assisted long-acting micro-depot cabotegravir intradermal delivery for HIV pre-exposure prophylaxis, Adv. Funct. Mater., 2106999
  15. Tomita, 2022, Prediction of corresponding dose of transdermal blonanserin to oral dose based on dopamine d2 receptor occupancy: unique characteristics of blonanserin transdermal patch, J. Clin. Psychopharmacol., 42, 260, 10.1097/JCP.0000000000001545 · DOI
  16. May, 2022, Why drug delivery is the key to new medicines, Nat. Med., 28, 1100, 10.1038/s41591-022-01826-y · doi:10.1038/s41591-022-01826-y
  17. McAlister, 2021, Directly compressed tablets: a novel drug-containing reservoir combined with hydrogel-forming microneedle arrays for transdermal drug delivery, Adv. Healthc. Mater., 10, 2001256, 10.1002/adhm.202001256 · DOI
  18. Demartis, 2022, Trilayer dissolving polymeric microneedle array loading Rose Bengal transfersomes as a novel adjuvant in early-stage cutaneous melanoma management, Int. J. Pharm., 627, 10.1016/j.ijpharm.2022.122217 · doi:10.1016/j.ijpharm.2022.122217
  19. Vora, 2020, Pullulan-based dissolving microneedle arrays for enhanced transdermal delivery of small and large biomolecules, Int. J. Biol. Macromol., 146, 290, 10.1016/j.ijbiomac.2019.12.184 · DOI · Paper page
  20. Tekko, 2020, Localised and sustained intradermal delivery of methotrexate using nanocrystal-loaded microneedle arrays: potential for enhanced treatment of psoriasis, Eur. J. Pharm. Sci., 152, 10.1016/j.ejps.2020.105469 · DOI · Paper page
  21. Vora, 2021, Microneedle array systems for long-acting drug delivery, Eur. J. Pharm. Biopharm., 159, 44, 10.1016/j.ejpb.2020.12.006 · DOI · Paper page
  22. Naser, 2023, Hydrogel-forming microarray patches with solid dispersion reservoirs for transdermal long-acting microdepot delivery of a hydrophobic drug, J. Control. Release, 356, 416, 10.1016/j.jconrel.2023.03.003 · DOI
  23. Paredes, 2022, Ring inserts as a useful strategy to prepare tip-loaded microneedles for long-acting drug delivery with application in HIV pre-exposure prophylaxis, Mater. Des., 224, 10.1016/j.matdes.2022.111416 · DOI
  24. Peng, 2021, Dissolving microneedle patches loaded with amphotericin B microparticles for localised and sustained intradermal delivery: potential for enhanced treatment of cutaneous fungal infections, J. Control. Release, 339, 361, 10.1016/j.jconrel.2021.10.001 · DOI
  25. Anjani, 2021, Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs, Eur. J. Pharm. Biopharm., 158, 294, 10.1016/j.ejpb.2020.12.003 · DOI
  26. Paredes, 2021, Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride, Int. J. Pharm., 606, 10.1016/j.ijpharm.2021.120885 · DOI
  27. Volpe-Zanutto, 2021, Artemether and lumefantrine dissolving microneedle patches with improved pharmacokinetic performance and antimalarial efficacy in mice infected with Plasmodium yoelii, J. Control. Release, 333, 298, 10.1016/j.jconrel.2021.03.036 · DOI
  28. Pamornpathomkul, 2018, Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery, Eur. J. Pharm. Sci., 121, 200, 10.1016/j.ejps.2018.05.009 · DOI
  29. Abd-El-Azim, 2022, Hollow microneedle assisted intradermal delivery of hypericin lipid nanocapsules with light enabled photodynamic therapy against skin cancer, J. Control. Release, S0168-3659
  30. Clarke, 1981, Fluphenazeve decanoate, 275, 10.1016/S0099-5428(08)60144-6 · doi:10.1016/s0099-5428(08)60144-6
  31. Luo, 1997, Sensitive method for the simultaneous measurement of fluphenazine decanoate and fluphenazine in plasma by high-performance liquid chromatography with cuolometric detection, J. Chromatogr. B Biomed. Sci. Appl., 688, 303, 10.1016/S0378-4347(96)00287-3 · DOI
  32. Ramöller, 2022, HPLC-MS method for simultaneous quantification of the antiretroviral agents rilpivirine and cabotegravir in rat plasma and tissues, J. Pharm. Biomed. Anal., 213, 10.1016/j.jpba.2022.114698 · DOI
  33. Nasiri, 2022, Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery, Drug Deliv. Transl. Res., 12, 881, 10.1007/s13346-021-01107-0 · DOI · Paper page
  34. Chavda, 2017, A review on novel emulsification technique: a nanoemulsion, research & reviews, J. Pharmacol. Toxicol. Stud., 5, 29
  35. Wu, 2021, Long-acting nanoparticle-loaded bilayer microneedles for protein delivery to the posterior segment of the eye, Eur. J. Pharm. Biopharm., 165, 306, 10.1016/j.ejpb.2021.05.022 · doi:10.1016/j.ejpb.2021.05.022
  36. Wu, 2022, Nanosuspension-loaded dissolving bilayer microneedles for hydrophobic drug delivery to the posterior segment of the eye, Biomater. Adv., 137, 10.1016/j.bioadv.2022.212767 · doi:10.1016/j.bioadv.2022.212767
  37. Stewart, 2021, Poly (caprolactone)-based subcutaneous implant for sustained delivery of levothyroxine, Int. J. Pharm., 607, 10.1016/j.ijpharm.2021.121011 · DOI · Paper page
  38. Peng, 2021, Hydrogel-forming microneedles for rapid and efficient skin deposition of controlled release tip-implants, Mater. Sci. Eng. C, 127, 10.1016/j.msec.2021.112226 · DOI
  39. Abdelghany, 2019, Nanosuspension-based dissolving microneedle arrays for intradermal delivery of curcumin, Pharmaceutics., 11, 308, 10.3390/pharmaceutics11070308 · DOI
  40. Cordeiro, 2020, Two-photon polymerisation 3D printing of microneedle array templates with versatile designs: application in the development of polymeric drug delivery systems, Pharm. Res., 37, 10.1007/s11095-020-02887-9 · DOI
  41. Cárcamo-Martínez, 2021, Enhancing intradermal delivery of tofacitinib citrate: comparison between powder-loaded hollow microneedle arrays and dissolving microneedle arrays, Int. J. Pharm., 593, 10.1016/j.ijpharm.2020.120152 · DOI
  42. Courtenay, 2020, Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery, J. Control. Release, 322, 177, 10.1016/j.jconrel.2020.03.026 · doi:10.1016/j.jconrel.2020.03.026
  43. Matar, 2018, Fluphenazine (oral) versus placebo for schizophrenia, Cochrane Database Syst. Rev., 6
  44. Meyer, 2013, Understanding depot antipsychotics: an illustrated guide to kinetics, CNS Spectr., 18, 55, 10.1017/S1092852913000783 · DOI
  45. Gorain, 2014, Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats, Colloids Surf. B: Biointerfaces, 115, 286, 10.1016/j.colsurfb.2013.12.016 · DOI · Paper page
  46. Huang, 1995, The role of the lymphatic system in the presystemic absorption of fluphenazine after intramuscular administration of fluphenazine decanoate in rats, Eur. J. Pharm. Sci., 3, 15, 10.1016/0928-0987(94)00070-G · doi:10.1016/0928-0987(94)00070-g
  47. Aljabri, 2022, Nanoemulsion: an emerging technology for oilfield applications between limitations and potentials, J. Pet. Sci. Eng., 208, 10.1016/j.petrol.2021.109306 · DOI
  48. Nasiri, 2021, Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery, Drug Deliv. Transl. Res., 1, 3
  49. Rai, 2018, Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications, J. Control. Release, 270, 203, 10.1016/j.jconrel.2017.11.049 · DOI · Paper page
  50. Mahadev, 2022, Fabrication and evaluation of quercetin nanoemulsion: a delivery system with improved bioavailability and therapeutic efficacy in diabetes mellitus, Pharmaceuticals, 15, 70, 10.3390/ph15010070 · DOI
  51. El-Tokhy, 2021, Transdermal delivery of second-generation antipsychotics for management of schizophrenia; disease overview, conventional and nanobased drug delivery systems, J. Drug Delivery Sci. Technol., 61, 10.1016/j.jddst.2020.102104 · DOI
  52. Yazgan, 2020, Investigation of antimicrobial properties of sage essential oil and its nanoemulsion as antimicrobial agent, LWT, 130, 10.1016/j.lwt.2020.109669 · DOI
  53. Bali, 2010, Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe, Colloids Surf. B: Biointerfaces, 76, 410, 10.1016/j.colsurfb.2009.11.021 · DOI · Paper page
  54. Abu Sharar, 2021, Multiobjective optimization of fluphenazine nanocomposite formulation using nsga-ii method, Mater. Sci.-Pol., 39, 517, 10.2478/msp-2021-0042 · DOI
  55. Dunne, 2009, Fluphenazine release from biodegradable microparticles: characterization and modelling of release, J. Microencapsul., 26, 403, 10.1080/02652040802396575 · DOI
  56. Vora, 2018, Novel nanosuspension-based dissolving microneedle arrays for transdermal delivery of a hydrophobic drug, J. Interdiscip. Nanomed., 3, 89, 10.1002/jin2.41 · DOI
  57. Vora, 2014, Self-assembled nanocomplexes of anionic pullulan and polyallylamine for DNA and pH-sensitive intracellular drug delivery, J. Nanopart. Res., 16, 1, 10.1007/s11051-014-2781-8 · DOI
  58. Zhao, 2020, Preparation, characterization, and evaluation of antioxidant activity and bioavailability of a self-nanoemulsifying drug delivery system (snedds) for buckwheat flavonoids, Acta Biochim. Biophys. Sin. Shanghai, vol. 52, 1265, 10.1093/abbs/gmaa124 · DOI
  59. Ramalheiro, 2020, Rapidly dissolving microneedles for the delivery of cubosome-like liquid crystalline nanoparticles with sustained release of rapamycin, Int. J. Pharm., 591, 10.1016/j.ijpharm.2020.119942 · DOI
  60. Laxmi, 2015, Development and characterization of nanoemulsion as carrier for the enhancement of bioavailability of artemether, Artif. Cells Nanomed. Biotechnol., 43, 334, 10.3109/21691401.2014.887018 · DOI · Paper page
  61. Himawan, 2023, Multifunctional low temperature-cured PVA/PVP/citric acid-based hydrogel forming microarray patches: physicochemical characteristics and hydrophilic drug interaction, Eur. Polym. J., 186, 10.1016/j.eurpolymj.2023.111836 · doi:10.1016/j.eurpolymj.2023.111836
  62. Altuntaş, 2022, Nestorone nanosuspension-loaded dissolving microneedles array patch: a promising novel approach for “on-demand” hormonal female-controlled peritcoital contraception, Int. J. Pharm., 614, 10.1016/j.ijpharm.2021.121422 · DOI
  63. Rojekar, 2021, Etravirine-loaded dissolving microneedle arrays for long-acting delivery, Eur. J. Pharm. Biopharm., 165, 41, 10.1016/j.ejpb.2021.04.024 · DOI
  64. Faizi, 2022, Deferasirox nanosuspension loaded dissolving microneedles for intradermal delivery, Pharmaceutics, 14, 2817, 10.3390/pharmaceutics14122817 · DOI
  65. Lutton, 2015, Microneedle characterisation: the need for universal acceptance criteria and gmp specifications when moving towards commercialisation, Drug Deliv. Transl. Res., 5, 313, 10.1007/s13346-015-0237-z · DOI · Paper page
  66. Peng, 2021, Hydrogel-forming microneedles for rapid and efficient skin deposition of controlled release tip-implants, Mater. Sci. Eng. C, 127, 10.1016/j.msec.2021.112226 · DOI
  67. Rooseboom, 2004, Enzyme-catalyzed activation of anticancer prodrugs, Pharmacol. Rev., 56, 53, 10.1124/pr.56.1.3 · DOI · Paper page
  68. Luo, 1997, Studies on the mechanism of absorption of depot neuroleptics: fluphenazine decanoate in sesame oil, Pharm. Res., 14, 1079, 10.1023/A:1012165731390 · doi:10.1023/a:1012165731390
  69. Aravagiri, 1995, Distribution of fluphenazine and its metabolites in brain regions and other tissues of the rat, Neuropsychopharmacology, 13, 235, 10.1016/0893-133X(95)00070-T · DOI
  70. Coulter, 2023, Enzyme-triggered l-α/d-peptide hydrogels as a long-acting injectable platform for systemic delivery of HIV/AIDS drugs, Adv. Healthcare Mater.
  71. Crudden, 2018, Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension, J. Control. Release, 28, 119, 10.1016/j.jconrel.2018.11.002 · DOI
  72. Scheff, 2011, Assessment of pharmacologic area under the curve when baselines are variable, Pharm. Res., 28, 1081, 10.1007/s11095-010-0363-8 · DOI
  73. Permana, 2019, Solid lipid nanoparticle-based dissolving microneedles: a promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis, J. Control. Release, 316, 34, 10.1016/j.jconrel.2019.10.004 · DOI · Paper page
  74. Bhadale, 2023, A comparison of dissolving microneedles and transdermal film with solid microneedles for iloperidone in vivo: a proof of concept, Naunyn-Schmiedeberg’s, Arch. Pharmacol., 396, 239, 10.1007/s00210-022-02309-0 · doi:10.1007/s00210-022-02309-0
  75. Pires, 2022, Antipsychotics-loaded nanometric emulsions for brain delivery, Pharmaceutics, 14, 2174, 10.3390/pharmaceutics14102174 · DOI
  76. Cárcamo-Martínez, 2021, Hollow microneedles: a perspective in biomedical applications, Int. J. Pharm., 599, 10.1016/j.ijpharm.2021.120455 · DOI · Paper page
  77. McAlister, 2021, The role of microneedle arrays in drug delivery and patient monitoring to prevent diabetes induced fibrosis, Adv. Drug Deliv. Rev., 175, 10.1016/j.addr.2021.06.002 · DOI
  78. Volpe-Zanutto, 2022, Hydrogel-forming microarray patches with cyclodextrin drug reservoirs for long-acting delivery of poorly soluble cabotegravir sodium for HIV pre-exposure prophylaxis, J. Control. Release, 348, 771, 10.1016/j.jconrel.2022.06.028 · DOI
  79. Tekko, 2020, Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate, Int. J. Pharm., 586, 10.1016/j.ijpharm.2020.119580 · DOI · Paper page
  80. Magill, 2023, Solid implantable devices for sustained drug delivery, Adv. Drug Deliv. Rev., 199, 114950, 10.1016/j.addr.2023.114950 · DOI
  81. Zhang, 2023, Development of dissolving microneedles for intradermal delivery of the long-acting antiretroviral drug bictegravir, Int. J. Pharm., 642, 123108, 10.1016/j.ijpharm.2023.123108 · DOI

Metadata

Authors
Abu Ershaid, J. M., Vora, L. K., Volpe-Zanutto, F., Sabri, A. H., Peng, K., Anjani, Q. K., McKenna, P. E., Ripolin, A., Larrañeta, E., McCarthy, H. O., & Donnelly, R. F.
Venue
Biomaterials Advances
Publisher
Elsevier BV
Published
2023-10
Volume
153
Pages
213526
ISSN
2772-9508
Cited by
29
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microneedle array patches for sustained delivery of fluphenazine: A micron scale approach for the management of schizophrenia. https://app.cochat.ai/papers/10.1016/j.bioadv.2023.213526
The paper
Abu Ershaid, J. M., Vora, L. K., Volpe-Zanutto, F., Sabri, A. H., Peng, K., Anjani, Q. K., McKenna, P. E., Ripolin, A., Larrañeta, E., McCarthy, H. O., & Donnelly, R. F. (2023). Microneedle array patches for sustained delivery of fluphenazine: A micron scale approach for the management of schizophrenia. Biomaterials Advances. https://doi.org/10.1016/j.bioadv.2023.213526

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.